Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Body temperature, Chills, Cough, Dizziness
Clinical narrative: nausea; muscle aches; cough; mild dizziness; erratic heartbeat; moderate headache/moderate-to-severe headache; severe chills; fever/elevated fever of about 100-101 degrees; breathing difficulties (painful, going to back)/difficulty breathing with pain going through to back with each breath; breathing difficulties (painful, going to back)/difficulty breathing with pain going through to back with each breath; stomach ache; This is a spontaneous report received from a Consumer or other non HCP.  A 71-year-old female patient received BNT162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 22Feb2024 as dose 1, single (Batch/Lot number: unknown) at the age of 71 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hashimoto's" (unspecified if ongoing); "Known allergies: Unknown; some she cannot tolerate." (unspecified if ongoing); "hypertension" (unspecified if ongoing); "lymphedema" (unspecified if ongoing); "venous insufficiency" (unspecified if ongoing); "GERD" (unspecified if ongoing); "mild heart regurgitation" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DYSPNOEA (non-serious), PAINFUL RESPIRATION (non-serious) all with onset 22Feb2024, outcome "not recovered" and all described as "breathing difficulties (painful, going to back)/difficulty breathing with pain going through to back with each breath"; PYREXIA (non-serious) with onset 22Feb2024, outcome "not recovered", described as "fever/elevated fever of about 100-101 degrees"; ABDOMINAL PAIN UPPER (non-serious) with onset 22Feb2024, outcome "not recovered", described as "stomach ache"; HEART RATE IRREGULAR (non-serious) with onset 22Feb2024 at 18:30, outcome "not recovered", described as "erratic heartbeat"; DIZZINESS (non-serious) with onset 22Feb2024 at 18:30, outcome "not recovered", described as "mild dizziness"; HEADACHE (non-serious) with onset 22Feb2024 at 18:30, outcome "not recovered", described as "moderate headache/moderate-to-severe headache"; CHILLS (non-serious) with onset 22Feb2024 at 18:30, outcome "not recovered", described as "severe chills"; COUGH (non-serious) with onset 23Feb2024, outcome "not recovered"; MYALGIA (non-serious) with onset 23Feb2024, outcome "not recovered", described as "muscle aches"; NAUSEA (non-serious) with onset 23Feb2024, outcome "not recovered". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of dizziness, heart rate irregular, headache, chills, pyrexia, dyspnoea, painful respiration, abdominal pain upper, nausea, myalgia, cough. Additional information: By early evening she was experiencing mild dizziness, erratic heartbeat, moderate headache and severe chills. Later on in the evening she developed a fever, breathing difficulties (painful, going to back), and stomach ache. The next morning she woke up with elevated fever of about 100-101 degrees, moderate-to-severe headache, difficulty breathing with pain going through to back with each breath, muscle aches, chills, nausea, stomach ache and mild cough. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  The information on the batch/lot number for BNT162b2 omi xbb.1.5 will be requested and submitted if and when received.